Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant

Romano Silvestri, Gabriella Marfè, Marino Artico, Giuseppe La Regina, Antonio Lavecchia, Ettore Novellino, Manuela Morgante, Carla Di Stefano, Gianfranco Catalano, Giuseppe Filomeni, Elisabetta Abruzzese, Maria Rosa Ciriolo, Matteo Antonio Russo, Sergio Amadori, Roberto Cirilli, Francesco La Torre, Paola Sinibaldi Salimei

Research output: Contribution to journalArticlepeer-review

Abstract

Pyrrolo[1,2-b][1,2,5]benzothiadiazepine 5,5-dioxides (PBTDs) induced apoptosis in human BCR-ABL-expressing leukemia cells. The apoptotic activity was also observed in primary leukemic blasts, obtained from chronic myelogenous leukemia (CML) patients at onset or from patients in blast crisis and who were imatinib-resistant. Compounds 5 and 14 induced apoptosis before BCR-ABL protein expression and tyrosin phosphorylation were affected and activated different caspases in the apoptotic pathway. PBTDs are a new class of valid candidates for the treatment of CML.

Original languageEnglish
Pages (from-to)5840-5844
Number of pages5
JournalJournal of Medicinal Chemistry
Volume49
Issue number19
DOIs
Publication statusPublished - Sep 21 2006

ASJC Scopus subject areas

  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant'. Together they form a unique fingerprint.

Cite this